Shareholding disclosure

The Swiss Helvetia Fund Inc

Declared position

4.48%

Threshold

Crossed upwards

Timeline

Published

10.01.2012

Transaction

16.03.2011

Voting rights breakdown

Voting rights acquired4.48%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAC1900029

Beneficial owner

The Swiss Helvetia Fund Inc

Declared address

THE SWISS HELVETIA FUND, INC., NEW YORK 10020

Change in registered capital on March 16, 2011.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

The Swiss Helvetia Fund Inc

Addex Therapeutics Ltd10.01.2012TAC1900029

Disclosure summary

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 10.01.2012, at 4.48% of voting rights. Notice category: Single shareholder.

Disclosed position

4.48%

Voting rights acquired

Voting rights acquired4.48%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

The Swiss Helvetia Fund Inc disclosed a holding in Addex Therapeutics Ltd, published on 10.01.2012.

Publication date10.01.2012

Transaction date16.03.2011

Issuing companyAddex Therapeutics Ltd

Beneficial ownerThe Swiss Helvetia Fund Inc

Declared addressTHE SWISS HELVETIA FUND, INC., NEW YORK 10020

CategorySingle shareholder

Voting rights acquired4.48%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAC1900029

Conditions

Change in registered capital on March 16, 2011.

Source: SIX Exchange Regulation · Publication date: 10.01.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open